• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT CG8+ CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT CG8+ CARTRIDGE Back to Search Results
Catalog Number 03P88-25
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/26/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Apoc incident # (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
 
Event or Problem Description
On (b)(6) 2023, abbott point of care was contacted by a customer regarding i-stat cg8+ cartridges that yielded a suspected discrepant pco2 result on a less than 2 hour old, male patient.There was no additional patient information at the time of this report.Method date collected tested po2 pco2 hco3 so2 sample i-stat (b)(6) 2023 09:49 9:56 39.0 71.5 27.5 60.0 venous #1 ; ni (b)(6) 2023 09:49 9:49 47.8 49.5 21.3 87.0 venous #1.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The investigation is underway.
 
Additional Manufacturer Narrative
Apoc incident: # (b)(4).The investigation was completed on 06-mar-2023.A review of the device history record (dhr) confirmed the cartridge lot met finished goods release criteria.Retained cartridge testing met the acceptance criteria found in q04.01.003 rev.Ak, appendix 1 - product complaint level 2 and level 3 investigation procedure.A minimum sample size of 17 is required to determine whether the acceptance criterion has been met for rate of results outside of the total allowable error (ea).If a complaint is related to discrepant results and the sample size is below 17, testing is performed in attempt to reproduce the customer complaint.There are no minimum sample size requirements for assessing the acceptance criterion for rate of suppressed results.Returned cartridge testing did not reproduced the customer's observations and the suppressed results criterion was met.No deficiency has been determined for cg8+ cartridge lot w22282.
 
Event or Problem Description
Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT CG8+ CARTRIDGE
Common Device Name
CG8+ CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
Manufacturer (Section G)
ABBOTT POINT OF CARE CANADA LTD.
185 corkstown road
K2H 8 V4
CA   K2H 8V4
Manufacturer Contact
linda maczuszenko
400 college road
princeton, NJ 08540
6136885949
MDR Report Key16287117
Report Number2245578-2023-00014
Device Sequence Number4880971
Product Code CHL
UDI-Device Identifier10054749000163
UDI-Public10054749000163
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K940918
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/08/2023
Device Catalogue Number03P88-25
Device Lot NumberW22282
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 01/26/2023
Supplement Date Received by Manufacturer03/06/2023
Initial Report FDA Received Date02/02/2023
Supplement Report FDA Received Date03/07/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/09/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age1 DA
Patient SexMale
-
-